Evidence map›Paper›PMID 19265198›Full record

ArticleThe Journal of biological chemistry2009

Heat shock protein gp96 interacts with protein phosphatase 5 and controls toll-like receptor 2 (TLR2)-mediated activation of extracellular signal-regulated kinase (ERK) 1/2 in post-hypoxic kidney cells.

Sanae Ben Mkaddem, Catherine Werts, Jean-Michel Goujon, Marcelle Bens, Eric Pedruzzi, Eric Ogier-Denis, Alain Vandewalle

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Epigenetic regulation of Toll-like receptors 2 and 4 in kidney disease.Journal of molecular medicine (Berlin, Germany) · 2022
    Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Protein phosphatases in pancreatic islets.The Journal of endocrinology · 2014
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Dangers within: DAMP responses to damage and cell death in kidney disease.Journal of the American Society of Nephrology : JASN · 2011
    Review
  16. Review
  17. HMGB1 contributes to kidney ischemia reperfusion injury.Journal of the American Society of Nephrology : JASN · 2010
    Article
  18. Article
  19. The role of Toll-like receptors in renal diseases.Nature reviews. Nephrology · 2010
    Review
  20. The protective role of pregnane X receptor in lipopolysaccharide/D-galactosamine-induced acute liver injury.Laboratory investigation; a journal of technical methods and pathology · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Sanae Ben MkaddemINSERM U773, Centre de Recherche Biomédicale Bichat-Beaujon CRB3, UFR de Médecine Xavier Bichat, Université Paris 7-Denis Diderot, Site Bichat, BP 416, F-75870 Paris Cedex 18, France.
Catherine Werts
Jean-Michel Goujon
Marcelle Bens
Eric Pedruzzi
Eric Ogier-Denis
Alain Vandewalle
Délégation Paris 7 · FRUniversité Paris Cité · FRCentre Hospitalier Universitaire de Poitiers · FRInserm · FRInstitut Pasteur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ischemia/reperfusion injury (IRI) induces an innate immune response, leading to an inflammatory reaction and tissue damage that have been attributed to engagement of the Toll-like receptor (TLR) 2 and 4. However, the respective roles of TLR2 and/or TLR4 in mediating downstream activation of mitogen-activated protein kinase (MAPK) pathways during IRI have not been fully elucidated. Here we show that extracellular signal-regulated kinase (ERK)1/2 is activated in both intact kidneys and cultured renal tubule epithelial cells (RTECs) from wildtype and Tlr4 knockout mice, but not those from Tlr2 knockout mice subjected to transient ischemia. Geldanamycin (GA), an inhibitor of heat shock protein 90 and reticulum endoplasmic-resident gp96, and gp96 mRNA silencing (siRNA), did not affect ERK1/2 activation in either post-hypoxic wild-type or Tlr4-deficient RTECs, but did restore its activation in post-hypoxic Tlr2-deficient RTECs. Immunoprecipitation studies revealed that gp96 co-immunoprecipitates with the serine-threonine protein phosphatase 5 (PP5), identified as a negative modulator of the mitogen extracellular kinase (MEK)-ERK pathway, in unstressed wild-type and post-hypoxic Tlr2-deficient RTECs. In contrast, PP5 co-immunoprecipitation with gp96 was strikingly reduced in post-hypoxic wild-type RTECs, suggesting that the inactivation of PP5 resulting from the dissociation of PP5 from gp96 allows the activation of ERK1/2 to occur. Inhibition of PP5 by okadaic acid, and Pp5 siRNA also restored TLR2-mediated phosphorylation of ERK1/2, and apoptosis signal-regulating kinase 1 (ASK1)/c-Jun N-terminal kinase (JNK)-mediated apoptosis in post-hypoxic Tlr2-deficient RTECs. These findings indicate that gp96 interacts with PP5 and controls TLR2-mediated induction of ERK1/2 in post-hypoxic renal tubule cells.

Indexed as

MAP Kinase Signaling SystemAnimalsApoptosisBenzoquinonesEndoplasmic ReticulumEnzyme InhibitorsEpithelial CellsKidney DiseasesKidney TubulesLactams, MacrocyclicMAP Kinase Kinase Kinase 5Membrane GlycoproteinsMiceMice, KnockoutMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3BenzoquinonesendoplasminEnzyme InhibitorsgeldanamycinLactams, MacrocyclicMap3k5 protein, mouseMAP Kinase Kinase Kinase 5Membrane GlycoproteinsMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Nuclear ProteinsOkadaic AcidPhosphoprotein Phosphatasesprotein phosphatase 5Tlr2 protein, mouseTlr4 protein, mouseToll-Like Receptor 2Toll-Like Receptor 4

Identifiers

PMID19265198
PMCPMC2673320
OpenAlexW2082226075

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.